RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/19926609http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/19926609http://www.w3.org/2000/01/rdf-schema#comment"Circadian disruption has been linked with inflammation, an established cancer risk factor. Per3 clock gene polymorphisms have also been associated with circadian disruption and with increased cancer risk. Patients completed a questionnaire and provided a blood sample prior to undergoing a colonoscopy (n = 70). Adjusted mean serum cytokine concentrations (IL-6, TNF-alpha, gamma-INF, IL-1ra, IL-1-beta, VEGF) were compared among patients with high and low scores for fatigue (Multidimensional Fatigue Inventory), depressive symptoms (Beck Depression Inventory II), or sleep disruption (Pittsburgh Sleep Quality Index), or among patients with different Per3 clock gene variants. Poor sleep was associated with elevated VEGF, and fatigue-related reduced activity was associated with elevated TNF-alpha concentrations. Participants with the 4/5 or 5/5 Per3 variable tandem repeat sequence had elevated IL-6 concentrations compared to those with the 4/4 genotype. Biological processes linking circadian disruption with cancer remain to be elucidated. Increased inflammatory cytokine secretion may play a role."xsd:string
http://purl.uniprot.org/citations/19926609http://purl.org/dc/terms/identifier"doi:10.1177/1534735409352029"xsd:string
http://purl.uniprot.org/citations/19926609http://purl.uniprot.org/core/author"Zhang H."xsd:string
http://purl.uniprot.org/citations/19926609http://purl.uniprot.org/core/author"Wagner S."xsd:string
http://purl.uniprot.org/citations/19926609http://purl.uniprot.org/core/author"Xie D."xsd:string
http://purl.uniprot.org/citations/19926609http://purl.uniprot.org/core/author"Singh U.P."xsd:string
http://purl.uniprot.org/citations/19926609http://purl.uniprot.org/core/author"Wood P."xsd:string
http://purl.uniprot.org/citations/19926609http://purl.uniprot.org/core/author"Hofseth L.J."xsd:string
http://purl.uniprot.org/citations/19926609http://purl.uniprot.org/core/author"Burch J.B."xsd:string
http://purl.uniprot.org/citations/19926609http://purl.uniprot.org/core/author"Hebert J.R."xsd:string
http://purl.uniprot.org/citations/19926609http://purl.uniprot.org/core/author"Hrushesky W.J."xsd:string
http://purl.uniprot.org/citations/19926609http://purl.uniprot.org/core/author"Armstead C.A."xsd:string
http://purl.uniprot.org/citations/19926609http://purl.uniprot.org/core/author"Guess J."xsd:string
http://purl.uniprot.org/citations/19926609http://purl.uniprot.org/core/author"Ogoussan K."xsd:string
http://purl.uniprot.org/citations/19926609http://purl.uniprot.org/core/author"Youngstedt S.D."xsd:string
http://purl.uniprot.org/citations/19926609http://purl.uniprot.org/core/date"2009"xsd:gYear
http://purl.uniprot.org/citations/19926609http://purl.uniprot.org/core/name"Integr Cancer Ther"xsd:string
http://purl.uniprot.org/citations/19926609http://purl.uniprot.org/core/pages"329-336"xsd:string
http://purl.uniprot.org/citations/19926609http://purl.uniprot.org/core/title"Circadian disruption, Per3, and human cytokine secretion."xsd:string
http://purl.uniprot.org/citations/19926609http://purl.uniprot.org/core/volume"8"xsd:string
http://purl.uniprot.org/citations/19926609http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/19926609
http://purl.uniprot.org/citations/19926609http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/19926609
http://purl.uniprot.org/uniprot/#_A0A087WV69-mappedCitation-19926609http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19926609
http://purl.uniprot.org/uniprot/#_P56645-mappedCitation-19926609http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19926609